These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 3912845)
21. Safety boards must report their conclusions to IRBs. Maloney DM Hum Res Rep; 1999 Oct; 14(10):3. PubMed ID: 11658061 [No Abstract] [Full Text] [Related]
22. Ethical issues in human gene therapy. Walters L J Clin Ethics; 1991; 2(4):267-74; discussion 274-8. PubMed ID: 1804397 [No Abstract] [Full Text] [Related]
23. Health Research Extension Act of 1985. Public Law 99-158. United States US Statut Large; 1985; 99(Title IV Sections 1-12):. PubMed ID: 11686169 [No Abstract] [Full Text] [Related]
24. IRBs, data sharing, and privacy of human subjects. Maloney DM Hum Res Rep; 2002 Apr; 17(4):3. PubMed ID: 12374179 [No Abstract] [Full Text] [Related]
25. Evolution of the NIH guidelines. Milewski EA Recomb DNA Tech Bull; 1981 Dec; 4(4):160-5. PubMed ID: 7029672 [No Abstract] [Full Text] [Related]
26. US bioethics panel poised to judge local review boards. Macilwain C Nature; 1996 Oct; 383(6600):466. PubMed ID: 8849708 [No Abstract] [Full Text] [Related]
27. Ethical issues in clinical neurological research. Shore D; Berg K; Mullican C J Calif Alliance Ment Ill; 1994; 5(1):61-2. PubMed ID: 11653329 [No Abstract] [Full Text] [Related]
28. The regulation of human experimentation in the United States--a personal odyssey. Katz J IRB; 1987; 9(1):1-6. PubMed ID: 11649890 [No Abstract] [Full Text] [Related]
29. Ethics lobby forces rethink on growth hormones. Miller SK New Sci; 1992 Aug; 135(1834):9. PubMed ID: 11659508 [No Abstract] [Full Text] [Related]
30. The business of research. Krimsky S; Hubbard R Hastings Cent Rep; 1995; 25(1):41-3. PubMed ID: 7730052 [No Abstract] [Full Text] [Related]
31. Duke's hazards. Did medical experiments put patients needlessly at risk? Kaplan S; Brownlee S US News World Rep; 1999 May; 126(20):66-8, 70. PubMed ID: 10387890 [No Abstract] [Full Text] [Related]
35. Public regulation of recombinant dna gene therapy. McGarity TO; Shapiro SA J Leg Med; 1982 Jun; 3(2):185-210. PubMed ID: 6981676 [No Abstract] [Full Text] [Related]
36. Recombinant DNA research; actions under guidelines; notice -- B. Public Information brochure -- "Gene therapy for human patients. U.S. National Institutes of Health Fed Regist; 1990 Mar; 55(41):7438-41. PubMed ID: 11645684 [No Abstract] [Full Text] [Related]
37. The ethics of human gene therapy. Walters L Nature; 1986 Mar 20-26; 320(6059):225-7. PubMed ID: 3457268 [TBL] [Abstract][Full Text] [Related]
38. Public oversight is necessary if human gene therapy is to progress. Zallen DT Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831 [No Abstract] [Full Text] [Related]
39. Gene therapy: research in public. Culliton BJ Science; 1985 Feb; 227(4686):493-6. PubMed ID: 3880924 [TBL] [Abstract][Full Text] [Related]
40. The NIH "Points to Consider" and the limits of human gene therapy. Juengst ET Hum Gene Ther; 1990; 1(4):425-33. PubMed ID: 2078585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]